Prebet, T., Fenaux, P., & Vey, N. (2016, October). Predicting outcome of patients with myelodysplastic syndromes after failure of azacitidine: Validation of the North American MDS consortium scoring system. Haematologica.
Chicagoスタイル(17版)引用形式Prebet, Thomas, Pierre Fenaux, , Norbert Vey. "Predicting Outcome of Patients with Myelodysplastic Syndromes After Failure of Azacitidine: Validation of the North American MDS Consortium Scoring System." Haematologica Oct. 2016.
MLA(9版)引用形式Prebet, Thomas, et al. "Predicting Outcome of Patients with Myelodysplastic Syndromes After Failure of Azacitidine: Validation of the North American MDS Consortium Scoring System." Haematologica, Oct. 2016.
警告: この引用は必ずしも正確ではありません.